ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS

As filed

Subsection

06

NTEE code

S46

Classification

1000

Street

601 NEW JERSEY AVE NW STE 350

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Other organizations at this address

5 other organizations in the IRS Business Master File list the same street address. matched by us

This address is a suite or unit (STE 350). Organizations that share one are often clients of the same office-services firm, accountant or registered agent rather than related to each other.

We match the street line and ZIP code as the IRS gives them, ignoring case and outer spaces and nothing else, so "AVE" and "AVENUE" count as different streets and this list can miss some. A shared address can mean related organizations or a shared office, but it can also be a registered agent, a mail drop or a service provider holding mail for unrelated clients. It is not, by itself, evidence that two organizations are connected.

• ALLIANCE FOR MRNA MEDICINES INC

  EIN 93-3748726

• INTERNET KEEP SAFE COALITION

  EIN 87-0652102

• PARTNERSHIP FOR DSCSA GOVERNANCE INC PDG

  EIN 84-3708089

• PARTNERSHIP FOR FOOD TRACEABILITY I NC

  EIN 33-2081875

• VETERANS SUMMIT

  EIN 33-2796595

Mission and programs · 2024

• THE ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS (ACRO) REPRESENTS THE WORLD'S LEADING CLINICAL RESEARCH ORGANIZATIONS AND CLINICAL TECHNOLOGY COMPANIES. ACRO'S MEMBERS PROVIDE SPECIALIZED SERVICES THAT ARE INTEGRAL TO THE DEVELOPMENT OF DRUGS, BIOLOGICS, AND MEDICAL DEVICES. ACRO ADVANCES CLINICAL OUTSOURCING TO IMPROVE THE QUALITY, EFFICIENCY, AND SAFETY OF BIOMEDICAL RESEARCH. ACRO'S PRIORITIES IN 2024 INCLUDED: 1. A US FOCUS ON REGULATORY ADVOCACY, SPECIFICALLY REPRESENTING CLINICAL RESEARCH AND CLINICAL TECHNOLOGY COMPANIES IN POLICY DISCUSSIONS WITH THE FDA. (CONTINUED IN SCHEDULE O) 2. EU ADVOCACY FOCUSED ON REPRESENTING THE INDUSTRY IN POLICY DISCUSSIONS WITH THE EUROPEAN COMMISSION, THE EUROPEAN MEDICINES AGENCY, AND UK AND OTHER EU MEMBER STATE REGULATORY BODIES.3. REPRESENTING MEMBER COMPANIES TO OTHER REGULATORS AND INDUSTRY STAKEHOLDERS SUCH AS CUSTOMERS.

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. Earlier years are each on their own filing page.

Filings

• 2024

  Revenue

  $2,313,761

  Expenses

  $2,437,532

  Contributions

  $0

  Grants paid

  $210,000

• 2023

  Revenue

  $2,469,015

  Expenses

  $2,091,418

  Contributions

  $0

  Grants paid

  $0

• 2022

  Revenue

  $2,348,771

  Expenses

  $1,983,993

  Contributions

  $0

  Grants paid

  $0

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2021 · 990

  Revenue

  $2,241,906

  Expenses

  $1,872,014

  Assets (EOY)

  $2,656,292

• 2020 · 990

  Revenue

  $2,144,736

  Expenses

  $1,688,132

  Assets (EOY)

  $2,239,714

• 2019 · 990

  Revenue

  $1,956,421

  Expenses

  $1,598,172

  Assets (EOY)

  $1,793,332

• 2018 · 990

  Revenue

  $1,468,752

  Expenses

  $1,331,211

  Assets (EOY)

  $1,453,590

• 2017 · 990

  Revenue

  $1,710,235

  Expenses

  $1,638,868

  Assets (EOY)

  $1,300,486

• 2016 · 990

  Revenue

  $1,510,232

  Expenses

  $1,402,055

  Assets (EOY)

  $1,254,104

• 2015 · 990

  Revenue

  $1,510,272

  Expenses

  $1,592,397

  Assets (EOY)

  $1,150,414

• 2014 · 990

  Revenue

  $1,400,347

  Expenses

  $1,328,363

  Assets (EOY)

  $1,235,756

• 2013 · 990

  Revenue

  $1,350,341

  Expenses

  $1,102,569

  Assets (EOY)

  $1,137,625

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all.

Grants made

• SMART CURES CLINICAL RESEARCH LLC

  $50,000

  2024 · TO INCREASE CLINICAL TRIAL PARTICIPANT DIVERSITY AT THEIR SITE.

• K2 MEDICAL RESEARCH LLC

  $40,000

  2024 · TO INCREASE CLINICAL TRIAL PARTICIPANT DIVERSITY AT THEIR SITE.

• PREFERRED PRIMARY CARE PHYSICIANS INC

  $40,000

  2024 · TO INCREASE CLINICAL TRIAL PARTICIPANT DIVERSITY AT THEIR SITE.

• NEBRASKA CANCER SPECIALISTS

  $20,000

  2024 · TO INCREASE CLINICAL TRIAL PARTICIPANT DIVERSITY AT THEIR SITE.

• BROOKLYN CLINICAL RESEARCH

  $20,000

  2024 · TO INCREASE CLINICAL TRIAL PARTICIPANT DIVERSITY AT THEIR SITE.

• SUPERIOR CLINICAL RESEARCH LLC

  $20,000

  2024 · TO INCREASE CLINICAL TRIAL PARTICIPANT DIVERSITY AT THEIR SITE.

• RANDOMIZE NOW

  $20,000

  2024 · TO INCREASE CLINICAL TRIAL PARTICIPANT DIVERSITY AT THEIR SITE.

Where these grants went next →

Grants received

No itemized grant names this organization as a recipient. Only grants over $5,000 are itemized, and only by filers of the full Form 990.

Other IRS files